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In previous studies in this laboratory, a plaque assay was developed in which 
cells secreting antibodies lyric for nucleated cells could be enumerated as plaque- 
forming cells  (PFC) 1 (1-3). This procedure has been successfully employed in 
studies on the appearance, in the spleens of stimulated mice, of PFC producing 
antibodies  to  xenogenic  (1)  and  allogenic  (2,  3)  cell-surface  antigens  and  in 
studies on the genetic control of the magnitude of antibody response to certain 
alloantigens (4, 5). 
More recently these studies have been extended  to in vitro experiments in 
which normal mouse spleen cells were stimulated in cultures by allogenic thymus 
cells (6). Besides the expected PFC  response to 0-AKR antigen of stimulating 
cells, we observed the appearance of small numbers of PFC that  lysed thymus 
cells of all murine strains tested, including syngenic thymus cells.  This finding 
of in  vitro formation of what  appeared  to  be thymus-specific autoantibodies 
stimulated the present investigation. 
The major objective of this study was to find out the conditions under which 
the number of autoantibody-secreting PFC can be increased by in vitro stimula- 
tion of spleen cells with syngenic and autologous thymus cells or their products. 
In  addition  to  thymus cells,  murine  lymphoma L5178Y  cells were used  as  a 
target for the detection of PFC  and  of antibodies  released to  the  cell  culture 
medium. Most experiments dealt with  stimulation  of spleen cells from strain 
DBA/2J,  which  is syngenic with L5178Y lymphoma. However, other murine 
strains  were  also  included  in  these  studies  for  the  purpose  of  comparison. 
Finally, in vitro formation of thymus-specific autoantibodies was compared with 
in vivo formation of such antibodies by DBA/2J mice stimulated with syngenic 
thymus cells. 
* Supported by U.S. Public Health Service Research Grant AI-06754 from The National 
Institute of Allergy and Infectious Diseases. 
:~ Recipient of a Henry C. and Bertha H. Buswell Fellowship. Present address: Roswell 
Park Memorial Institute,  Buffalo, N. Y. 14203. 
1.4 bbreviations used in this paper: ME, 2-mercaptoethanol; PB S, phosphate-buffered saline; 
PFC, plaque-forming cells; TL, thymic leukemia antigen. 
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Materials and Methods 
Animals.--Female mice of inbred strains DBA/2J (DBA/2), AKR/J (AKR), NZB/BINJ 
(NZB), and C57BL/6J (C57BL/6), 8-10 wk old, were purchased from the Jackson Laboratory, 
Bar Harbor, Maine. (DBA/2 X  NZB)F1 hybrids were bred in the animal facility of this uni- 
versity. Fetuses of DBA/2 mice were obtained at 16-19 days of gestation. GestationM stages 
were estimated by counting the appearance of vaginai plugs as day 0. 
Cdl Cultures.--Cell  suspensions from spleen or thymus removed from an individual mouse 
or pooled from three to eight normal mice were prepared asepficaUy in cold balanced salt 
solution, pH 7.2,  by pressing the minced tissues through stainless steel wire screen, 50 mesh, 
and then filtering through 200-mesh screen. The resulting cell suspensions were centrifuged at 
200 g for  10 min at 4°C and resuspended in an appropriate volume of the culture medium. 
The cell concentration of the suspensions was determined by counting ceils stained with crystal 
violet; and the cultures were prepared in plastic Petri dishes, 35 mm in diameter, by the tech- 
nique of Mishell and Dutton  (7), with slight modifications. RPMI  1640  medium was used 
rather than Eagle's medium; it was supplemented with 5% fetal calf serum (Rehatuin, Reheis 
Chemical Co., Chicago, Ill.). Each culture consisted of 1 ml of a suspension containing 2 X  107 
spleen cells or 2 X  107 thymus ceils or a mixture of l07 spleen ceils and 107 thymus cells. In 
some experiments, cells of an individual surgically removed spleen were cultured.  LS178Y 
lymphoma cells were also cultured in a few experiments, 1 ml of a suspension containing  106 
cells being used. The cultures were maintained in an atmosphere of 10% CO2,7% 0,2, and 
83% N2 and "fed" daily with 0.1 ml of nutritional mixture (7). Supernatants of cultures were 
separated from cells by centrifugation at 200 g for 10 min at 4°C and stored at --70°C until 
tested for cytolytic antibodies. 
To test the supernatants of thymus cell cultures for their activity to stimulate spleen cell 
cultures,  the supernatants were made cell free by filtration through Nuclepore membranes 
(General Electric Co.,  Pleasanton,  Calif.),  pore size 0.5/zm, and used  immediately or after 
storing at -70°C.  To 0.5 ml of spleen cell  cultures containing 2  X  107 cells,  0.5 ml of the 
cell-free supernatants were added at time 0. 
Murine Lymphoma Cells.--DBA/2 lymphoma cell line L5178Y,  which was established and 
cloned by Fischer (8), and C57BL/6 lymphoma, EL4, were maintained in syngenic mice as an 
ascites tumor by weekly transfer of 0.1 ml of ascitic fluid. Ascites ceils were harvested 6-7 days 
after transplantation of the tumor. 
PFC Assay.--Cultured cells harvested from three dishes were pooled. Mter centrifugation 
at 200 g for 10 rain, cells were resuspended in 0.9 ml of M199 and were assayed for PFC by 
the previously described procedure, but with slight modifications (2, 3). Lymphoma LS178Y 
or thymus cells were employed as target cells.  To 0.3 ml of 0.7%  Difco-Bacto agar  (Difco 
Laboratories, Detroit, Mich.) dissolved in M199 and containing 0.5 mg DEAE-dextran/ml 
were added, at 45°C, 0.05 ml of the target cell suspension (5 X  106 L5178Y or 2 X  107  thymus 
cells) and 0.05-0.1  ml of cultured cell suspension. The mixture was spread on a  microscopic 
slide precoated with a 0.1% agar. Slides were placed in a humidified chamber and incubated for 
1 h  at 37°C in an atmosphere of 5% CO`2 in air. Fresh rabbit serum diluted  1:10 in M199 
(complement) was added, and the slides were kept for 1~ h at 4°C and for 1 h at 37°C. There- 
after slides were fan-dried, fixed in 95% ethanol for ~  h, rinsed in tap water, and dried again. 
Plaques were counted on unstained slides under strong, indirect illumination. Each sample was 
assayed in triplicate, and the number of PFC recovered per dish (culture) was calculated. 
The assay for PFC producing antibodies to sheep red cells  (SRC)  was done in a  similar 
manner except that 0.05 ml of a  5% suspension of SRC were added per slide as target and 
fresh guinea pig serum diluted 1 : 10 was used as a source of complement. 
Titration of Cytolytic Antibodies by Spot Tests.--Supernatants of cultures were usually con- 
centrated about five times by means of osmotic dialysis against hypertonic sucrose solution, ]8  IN  VITRO FORMATION OF  THYMUS-SPECIFIC  AUTOANTIBODIES 
which was followed by dialysis against phosphate-buffered  saline (PBS), pH 7.2. If not studied 
immediately, supernatants were preserved at -  70°C. 
Titration of antibodies by cytolysis in agar, by spot tests, was carried out by the previously 
described procedure, with slight modifications (2).  The agar layer containing proper target 
cells was prepared as in the PFC assay except that target cells alone were added to the agar. 
5 #1 of twofold serial dilutions of supernatants were placed on the surface of an agar layer 
containing proper target cells, and the preparations were left in a humid chamber at 4°C for 
1 h. Slides were washed for 1/6 h in cold Hanks' solution and incubated at 37°C for 1 h with 
rabbit serum diluted 1 : 10 in M 199 (complement), or M 199 alone as control. Thereafter, slides 
were processed as in the PFC assay. Cytolysis could be recognized as a circular refractile spot 
under indirect illumination. The reciprocal of the highest dilution of the supernatant at which 
partial but still definite cytolysis was observed was taken as the endpoint titer. Each titration 
was done in duplicate. 
Absorption of Antibodies.--Absorption of antibodies was performed by adding graded num- 
bers of lymphoid cells to 0.2 ml of the supernatant and mixing them continuously on an electric 
rotator for I-2 h at 4°C. In the case of absorptions with liver and kidney ceils, the cells were 
mechanically dispersed in cold M199  from the tissues of normal mice in a manner similar to 
that described for lymphoid cells. They were washed three times in cold M199 and sedimented 
by centrifugafion at 8,000 g for 10 rain. 0.2 ml of packed cells were mixed with an equal volume 
of the supernatant at 4°C and processed in a manner similar to that described for lymphoid 
cells. Supernatants were separated by centrifugation at 8,000 g for 10 min. Up to three absorp- 
tions were conducted. For control absorptions, suspensions of cells heated at  100°C for 15 
rain were used. In some experiments, absorption was carried out at 22°C and at 37°C as well as 
at 4°C. 
Physicochemical Characterization of Antibodies.--Gel filtration was carried out by using a 
Sephadex G-200 column (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), 30 cm >( 1.5 cm, 
equilibrated with 0.01 M PBS, pH 7.2. 1 ml of a concentrated culture supernatant was placed 
on the column, and 2-ml fractions were collected.  Sucrose density gradient centrifugation was 
done by layering 0.5 ml of a concentrated supernatant on 4.0 ml of a preformed linear gradient 
of sucrose ranging from 0.3  to 0.7 M  and centrifuging at 130,000 g for 18 h. Fractions were 
dialysed against PBS at 4°C for 18 h before titration for cytolytic antibodies. 
Mercaptoethanol Treatment.--Equal volumes of a supernatant and 0.1 M 2-mercaptoethanol 
(ME) were mixed and incubated for 1 h  at 37°C.  Titration was done after dialysing ME- 
treated samples for 18 h against PBS at 4°C. 
In  Vivo Stimulation  with Syngenic Thymus Cells.--Normal  DBA/2  mice  were  in- 
jected  intravenously with 0.1  ml  of a cell suspension containing 8 >(  107  syngenic thymus 
cells, prepared in cold M199 in a manner similar to that described above. Heparin at a dose 
equivalent to 10 USP units was given intraperitoneally to each animal before the injection of 
thymus cells. Uninjected mice served as controls. 
RESULTS 
In  Vitro Development of PFC Detectable on Syngenic  Thymus and Lymphoma 
Cdl  Targets.--Lymphoid  cells  from  normal  individual  DBA/2  mice  were 
cultured as described under Materials and Methods. Three groups of cultures-- 
spleen cells alone (S),  thymus cells alone (T), and a  mixture of equal numbers 
of spleen and thymus cells (S+T)--were  prepared with a  total cell inoculum of 
2  X  107  cells per culture.  The  cultured cells were examined by plaque  assay 
with DBA/2  thymus or LS178Y lymphoma cells as targets (Table I). Virtually 
no PFC were detected at time 0. In the course of cultures, S developed a  small H.  FUJI  AND  F.  MILGROM  19 
TABLE I 
PFC in  Cultures  of S,  T, or S  +  T. Assays  on Autologous  and  Syngenic  Thymus  Cells and 
L517gY Lymphoma Cells 
Animal no.  Cells  in culture 
PFC/culture, day 4, assayed on 
DBA/2 thymus  L5178Y 
S  5  18 
S +  T*  11  498 
T  0  0 
S  12  7 
S +  T*  4  90 
T  0  0 
3  S  6  (6)  9 
S+T  13  (12)  278 
4  S  16  (15)  20 
S +  T  18  (31)  184 
S  n.t.  24 
S +  T*  n.t.  572 
S +  T  n.t.  670 
T  n.t.  0 
S  n.t.  95 
S +  T*  n.t.  892 
S +  T  n.t.  832 
T  n.t.  0 
S  n.t.  30 
S +  T*  n.t.  514 
S +  T  n.t.  594 
T  nt.  0 
S and T  from individual DBA/2 mice were cultured alone with an initial cell inoculum of 
2 X  107 cells per culture. S +  T* was an autologous cell mixture of l0  T S and 107 T. S +  T 
indicates a similar mixture except that T  was pooled from three to five syngenic mice. The 
numbers in parentheses are the number of PFC detected on thymus target cells autologous 
with S. n.t.,  not tested. 
number of PFC  that released antibodies lyric to syngenic  thymus cells, scoring 
an average of 10 PFC per culture on day 4. In S+T  cultures,  a number of PFC 
similar to that in S  cultures was demonstrated  on a  syngenic thymus target. In 
some  experiments,  autologous  thymus  cells were  used  in  parallel  to  syngenic 
thymus  cells as a  target for PFC.  Comparable  numbers  of PFC  were detected 
on autologous and syngenic targets. Assays of S cultures on L5178Y lymphoma 
cells  as  target  showed  PFC  in  numbers  similar  to  those  noted  in  assays  on 
syngenic  thymus  target.  In  S+T  cultures,  on  the  other  hand,  a  markedly 20  IN  VITRO ~FOR~CfATION O~F  THYMUS-SPECIFIC  AUTOANTIBODIES 
increased number of PFC was demonstrated on L5178Y lymphoma cells.  The 
numbers scored on day 4 varied from 90 to 892 PFC per culture among seven 
individual animals tested. S+T cultures composed of autologous and of syngenic 
cells showed comparable numbers of PFC detectable on an L5178Y target. No 
PFC detectable on either thymus or LS178Y targets were noted in T  cultures. 
Fig.  1 illustrates  the  time course of  the  appearance of PFC detectable on 
L5178¥ cells. In S+T cultures, 410 PFC per culture were scored on day 4, 27 
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Fla.  1. The appearance in lymphoid cell cultures of DBA/2 mice of PFC detectable on 
L5178Y  lymphoma cells. Spleen cells (S) and thymus cells (T) were pooled from eight normal 
DBA/2 mice and cultured alone with an initial cell inoculum of 2  X  l0  T cells per culture. 
S +  T was a mixture of 107 S and 107 T. At each time point the cultured cells harvested from 
three dishes were pooled and assayed for PFC with L5178Y cells as the target. 
times more than in S cultures. The PFC number declined below 100 PFC per 
culture on days 5 and 6. 
In order  to  clarify whether  the presence of thymus cells  themselves is  re- 
quired for the enhancement of the PFC response directed  to L5178¥ cells  in 
S+T  cultures,  we  have  examined  the  effects  of cell-free  supernatants  of T 
cultures on such responses. As shown in Table II, the enhanced PFC response 
to L5178Y could be induced by adding cell-free supernatants of 24-96-tl cultures 
of T  to S cultures at time 0. The supernatants of the T cultures of 24 h already 
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Similar results were obtained with cell-free supernatants of L5178Y  cultures 
whereas those of S cultures were without effect. The observed enhancement did 
not seem to be due  to  any nonspecific enhancing  factor(s)  because  anti-SRC 
PFC that appeared without addition of SRC in S cultures were not affected by 
the addition of T  or L5178Y supernatants. 
Cytolytic Antibodies Appearing  in the Culture Supernatants.--Culture  super- 
natants were tested for antibodies lyric to syngenic thymus and L5178Y  cells 
by means of spot tests. Hardly any lysis of these target cells was induced by 
TABLE II 
Effect of Cell-Free Supernatants of the Cultures of T, S,  and L5178Y on the PFC Response 
to L5178Y 
Experiment  Cells in cultures  Cell-free supernatants added  no. 
PFC/culture, day 4, assayed on 
LS178Y  SRC 
S  --  8  108 
S  T, 24 h*  298  99 
S  T, 48 h*  330  93 
S  T, 72 h*  264  84 
S  T, 96 h*  264  93 
S +  T  --  242  66 
S  --  14  453 
S  T, 48 h*  404  267 
S  S, 48 h*  18  272 
S  L5178Y, 48 h*  840  171 
S  +  T  --  482  327 
Supernatants of DBA/2 T or S cultures, 2 X  107 cells per culture, or of L5178Y, 106 cells 
per culture, were made cell free  as described  under Materials and Methods. To 0.5 ml of 
DBA/2 S cultures containing 2 X  t07 cells, 0.5 ml of the cell-free supernatants were added at 
time 0. As a control, 0.5 ml of the fresh culture medium replaced the supernatants. S +  T was 
a mixture of 107 DBA/2 S and 107 DBA/2 T. 
* The length of the time for which T, S, or L5178Y cells were cultured before the super- 
natants were separated from the cells. 
any supernatants  except those  of  S+T  cultures,  in which  antibodies lyric to 
L5178Y  cells could be shown with an average titer of 1:16  on day 5  (Fig. 2). 
Physicochemical analysis of such antibodies in the concentrated supernatants 
of S+T  cultures was carried out by means of gel filtration on Sephadex G-200 
and sucrose density gradient centrifugation (Fig. 3). Antibodies lyric to L5178Y 
ceils were demonstrated in the first peak of Sephadex fractions and in the bottom 
fractions of the sucrose density gradient. Reductions of the antibodies by ME 
completely abolished their cytolytic activity. These results indicated that  the 
antibodies under study were of the IgM class. 
Absorption  of Antibodies Lytic to L5178Y Cells with Cells from Normal Syn- 
genie Mice.--In order to find out whether the antibodies lyric to L5178Y  cells 22  LN  VITRO  t'ORMATION  OF  TIIYMUS-SPECIFIC  AUTOANTIBODIES 
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Fio. 2. The appearance of antibodies lyric to LS178Y lymphoma  cells in the supernatants 
of lymphoid  cell cultures of DBA/2 mice. Supernatants of the cultures from the experiments 
shown in Fig. i were separated from cells by centrifugation at 200 g for l0 rain and stored at 
--  70°C until tested. Titration of cytolytic  antibodies in unconcentrated supernatants was done 
by spot tests with L5178¥ cells as the target. 
that  appeared  in  S+T  cultures  were  directed  to antigens present  on normal 
syngenic cells or to antigens expressed only on LS178Y cells, absorption of the 
supernatants of S+T cultures by cells from normal syngenic mice was carried 
out. As shown in Table III, antibodies lytic to LS178Y cells could be completely 
absorbed from concentrated supernatants of S+T cultures by thymus cells of 
normal DBA/2 mice or by L5178V cells.  Similar results were obtained when 
cells  of a  surgically removed spleen were cultured with syngenic thymus cells 
and the culture supernatants were absorbed with thymus cells autologous with 
the spleen cells. Thymus cells or L5178¥ cells heated at 100°C for 15 min did 
not absorb antibodies. 
The absorption  experiments  also demonstrated  that  removal of antibodies 
was more efficient  at 4°C  than at 22°C. At 37°C hardly any absorption took 
place  (Fig. 4). Absorption with spleen,  lympla  node and bone marrow cells  as 
well  as with  erythrocytes at numbers  comparable with  those of thymus cells 
failed to affect antibodies. Multiple absorptions with packed  cells  of liver  and 
kidney also failed to cause any significant reduction of the titer of supernatants, 
and the results obtained with fresh and heated cells were similar. 
The antigen thus demonstrated in normal thymus was not restricted  to the 
DBA/2  strain.  Absorptions of the  supernatants  with  thymus cells  of normal 
AKR and C57BL/6 mice removed antibodies as effectively as absorptions with 
DBA/2  thymus cells  (Table  III). On  the  other hand,  C57BL/6 lymphoma, 
EL4, did not absorb antibodies. H,  FUJI  AND  ~'. ]VIILGROM  23 
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Fie. 3.  (a)  Gel filtration of supernatant of S  +  T  cultures of DBA/2 mice on Sephadex 
G-200 column, 30 cm X  1.5 cm, equilibrated with 0.01 M  PBS, pH 7.2. I ml of a concentrated 
supernatant was placed on the column and 2-ml fractions were collected.  (b) Sucrose density 
gradient centrifugation of supernatant of S 4- T  cultures of DBA/2 mice. 0.5 ml of a concen- 
trated supernatant was layered on 4.0 ml of a preformed linear gradient of sucrose  ranging 
from 0.3 to 0.7 M  and centrifuged at 130,000 g for 18 h. Fractions were dialyzed against PBS 
for 18 h  before  titration for antibodies. Titration of cytolytic antibodies in each fraction was 
done by spot tests with L5178Y cells as the target. 
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TABLE  III 
Absorption  of Antibodies  to  L5178Y  in  the  Concentrated  Supernatants  of  S  +  T 
Strains of  cell donors  Cells used for absorption 
Titer of antibodies  to LSI78Y 
in the supernatants of S -t- T 
Number of  ....  with  absorptions ~soroea 
Fresh  Heated  Unabsorbed 
cells  cells* 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
DBA/2 
AKR 
C57BL/6 
C57BL/6 
Thymus, 2  X  10  s cells  1  2  128  256 
Thymus, fetal,;~ 5  X  107 cells  1  <2  128  256 
L5178Y, 5  X  107 cells  1  <2  128  128 
Spleen, 2  X  10  s cells  1  64  64  256 
Lymph node, 2  X  10 s cells  1  64  64  256 
Bone marrow, 2  X  108 cells  1  64  64  256 
Erythrocytes, 2  X  10  s cells  1  64  64  256 
Liver, 0.2 ml of packed cells  1  32  32  128 
Liver, 0.2 ml of packed cells  3  32  32  128 
Kidney, 0.2 ml of packed cells  1  64  64  128 
Kidney, 0.2 ml of packed cells  3  32  32  128 
Thymus, 2  N  108 cells  1  <2  128  256 
Thymus, 2  X  108 ceils  1  <2  128  256 
EL4, 2  X  10 s cells  1  64  64  128 
The supernatants of S  -b T  cultures of DBA/2 mice were osmoticaIly concentrated about 
five times.  Absorption  was  carried  out  by  adding cells to  0.2  ml  of the  supernatants and 
mixing them continually for 2  h  at 4°C  or,  in the case of multiple absorptions,  1 h  for each 
absorption. Titration of cytolytic antibodies was done by spot tests with L5178¥ cells as the 
target. 
* Cells were heated at  100°C for 15 rain. 
2~ Fetuses at day 16-19 of gestation. 
The results described above provided evidence that  the antibody response 
to  L5178Y  that  occurred in  S+T  cultures  of DBA/2  mice was  directed  to 
antigens present on thymus cells of all murine strains tested, including syngenic 
and autologous thymus cells. 
Fig.  5  illustrates  the  quantitative  absorption  of  antibodies  with  graded 
numbers of normal syngenic thymus and L5178Y cells.  It was shown in this 
experiment that the absorbing efficiency of LS178Y cells was 30 times greater 
than that of normal thymus cells, indicating that the antigen under discussion 
may either be more strongly expressed on LS178Y than on thymus cells or be 
expressed only on a minor population of thymus cells. 
Demonstration of the Antigen  on Fetal Thymus.--Since  the results suggested 
that normal adult DBA/2 spleen cells could recognize an antigen present in the 
animal's  own  thymus and  respond to  it in  vitro with  the formation of anti- 
bodies,  experiments  were  carried  out  to  determine  whether  this  antigen  is 
present during fetal life. Thymus cells from 16-19-day-old fetuses of DBA/2 
mice were pooled and  used for absorption of supernatants  of S+T  cultures. 
Antibodies lytic to L5178¥ cells could be completely removed by fetal thymus H.  ~'IIJI  AND  Y.  MILGROM  25 
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Fro. 4. Absorption at different temperatures of cytolytic antibodies from the supernatants 
of S  n  u T  cultures of DBA/2 mice. To 0.2-ml samples of a concentrated  supernatant, graded 
numbers of L5178Y  cells were added. The mixtures were kept continuously rotated for 2 h at 
different temperatures as indicated. Titration of cytolytic antibodies remaining in the super- 
natants was done by spot tests with LS178Y cells as the target. 
cells (Table III). It was also demonstrated that the supernatants  of 24-48-h 
cultures  of T  from  16-day-old fetuses stimulated  PFC  responses  to  L5178Y 
cells in adult S cultures as effectively as similar preparations from adult thymus 
cells (Table IV). 
PFC Response  Against  L5178Y  in  S+ T  Cultures from  Strains  Other than 
DBA/2.--As shown above, the thymic antigen under study was not restricted 
to the DBA/2 strain, but could be demonstrated in all other strains tested. We 
next studied whether spleen cells of strains other than DBA/2 respond to this 
antigen  upon  stimulation  in  vitro  with  syngenic  or  allogenic  thymus  cells. 
Experiments performed with syngenic S-t-T cultures of strains C57BL/6 and 
NZB  as  well  as  (DBA/2  X  NZB)F1  hybrids  (Table V)  did  not  show  any 
significant increase in the number of PFC detectable on L5178Y when compared 
with S. Hardly any increase of the PFC number was demonstrated in S cultures 
of NZB  and  (DBA/2  X  NZB)F1 origin by the addition of T  from allogenic 
mice. In contrast, S cultures from DBA/2 showed the expected increase in the 
number  of  PFC  detectable  on  L5178Y  upon  addition  of  T  from  NZB  or 
(DBA/2 X  NZB)F1 as well as from DBA/2. 26  IN  VITRO  FORMATION  OF  THYMUS-SPECIFIC  AUTOANTIBODIES 
3~ 
q 
?d 
cJ 
3h 
r 
© 
L) 
12ol 
64  '  • 
32 
16 
Y  Cells 
4 
2  Thymus  cells 
<2  '  'q'G  i  i  II'  J, 
6×10 5  2x10  ~×10  G  2x10 7  6x10 7  2X10 8 
Number  of  ceJIs  used  for  absorption 
FIG. 5. To 0.2-ml samples of a concentrated supernatant of S A- rF cultures of DBA/2 mice, 
graded  numbers of DBA/2  thymus cells and L5178Y  cells were added.  The mixtures were 
rotated continuously for 2 h at 4°C. Titration of cytolyfic  antibodles remaining in the super- 
natants was done by spot tests with L5178Y cells as the target. 
TABLE  IV 
Effects  of  Cell-Free Supernatants  of  Fetal  and  Adult  T  C*dtures 
Cells in culture  Cell-free  supernatants of T  cultures  PFC/culture, day 4,  assayed on L5178Y 
S  --  78 
S  Fetal, 24 h*  672 
S  Fetal, 48 h*  736 
S  Adult, 24 h*  454 
S  Adult, 48 h*  358 
S A- T  --  244 
Supernatants of fetal or adult DBA/2 T  cultures, 2  X  l0  T  ceils per culture, were made cell 
free as described under Materials and Methods. Fetal T  cells were obtained at day 16 of gesta- 
tion. To 0.5  ml of adult  DBA/2  S cultures  (2  X  10  7 cells  per culture)  were  added  0.5  ml 
of the cell-free supernatants at time 0. As a control, 0.5  ml of the fresh medium replaced the 
supernatants. S +  T  was a mixture of 10  T S and 10  7 T  of adult DBA/2 mice. 
* The length of the time for which T cells were cultured before supernatants were separated 
from the cells. ft.  fUJI  AND  ~.  MILGROM  27 
TABLE V 
Effects of the Strain on the PFC Response to L5178Y  Cells Occurring in the Cultures of 
SandS+  T 
Cells in culture  PFC/culture, day 4, 
assayed on LS178Y 
S  T  cells 
C57BL/6  --  51 
C57BL/6  C57BL/6  33 
NZB  --  32 
NZB  NZB  70 
NZB  DBA/2  48 
NZB  (DBA/2 X NZB)F1  94 
(DBA/2 X  NZB)F1  --  22 
(DBA/2 X NZB)F1  NZB  50 
(DBA/2 X NZB)F1  DBA/2  48 
(DBA/2 X NZB)Fx  (DBA/2 X  NZB)F1  50 
DBA/2  --  10 
DBA/2  NZB  360 
DBA/2  DBA/2  424 
DBA/2  (DBA/2 X NZB)F1  326 
S and T  cells pooled from three or four mice of each strain were employed for these ex- 
periments.  The initial cell inoculum  of S culture was 2  X  l0  T cells per culture. S +  T  was 
a mixture of 107 S and l0  T  T. 
In  Vivo  Stimulation  with  Syngenic  Thymus  Cdls.--Finally,  DBA/2  mice 
were  injected  intravenously  with  syngenic  thymus  cell  suspensions  to  see 
whether spleen cells of such mice could respond also in vivo to the antigen under 
study. Development in the spleen of PFC  detectable on L5178Y  was demon- 
strated on day 4  after the intravenous injection of 8  X  107  syngenic thymus 
cells in  all of 10  animals.  PFC  ranged from  130  to 3,060  per spleen,  the geo- 
metric  mean  number  being  741.  The  appearance  of serum  antibody lytic to 
L5178Y cells could also be shown in these animals. Among 10 uninjected control 
animals, 8 had fewer than 20 PFC in their spleens, and 2 animals had 38 and 83 
PFC per spleen, respectively. 
DISCUSSION 
The results of this study have shown that spleen ceils of normal DBA/2 mice 
have  the  capacity to  form  in  vitro  antibodies directed  to  certain  antigen(s) 
present on the animal's own thymus as well as to syngenic lymphoma L5178Y 
ceils. By  means  of plaque  assay we found  that  S  cultures developed a  small 
number of PFC detectable on both syngenic thymus and L5178Y cells, whereas 
S+T  cultures  developed  a  markedly  increased  number  of  PFC  that  were 28  LXI VITRO FORMATION OF  THYMUS-SPECIFIC AUTOANTIBODIES 
detectable on LS178Y cells,  but not on thymus cells.  It seems, therefore,  that 
two populations of antibody-forming ceils participated in the observed reactions. 
One population of PFC was detectable in S cultures by the lysis of syngenic 
thymus cells and possibly also LS178Y cells.  This population did not seem to be 
affected by adding T  to S cultures. The spontaneous occurrence in S cultures of 
the  PFC  that  released  antibodies  lyric to  syngenic  thymus  cells has  already 
been demonstrated in a  previous in vitro study (6), and seems to be a  general 
phenomenon  occurring  in  spleen  cell  cultures  of  any mouse  strain.  These  in 
vitro results are consistent with the in vivo observations that mice of various 
strains have in their sera the natural  autoantibodies cytotoxic to thymus cells 
(9,  10).  In our in  vitro experiments, however,  such  antibodies  were also pro- 
duced  by the  spleen  cells of all  the mice, which  were only 8  wk old  (younger 
animals were not tested),  whereas mice studied for serum antibodies by other 
investigators  were positive after 5  mo  of age.  The  significance  of such  auto- 
antibody formation remains unclarified. 
The other population of PFC detectable on LS178Y cells but not on thymus 
ceils was demonstrated in S-]-T cultures only, though  a  small number of PFC 
of this population might possibly be present in S cultures. They appeared in the 
cultures apparently as a result of the stimulation of S with certain immunogenic 
substances released by T. This assumption is supported by the fact that cell- 
free supematants of T  cultures or of L5178¥ cultures added to the syngenic S 
cultures induced a specific increase in the number of PFC detectable on L5178¥. 
The obvious explanation for the stimulation of syngenic and even autologous 
S  by the  substances  released from T  would  be  that  the  immune response is 
directed  against  antigens  altered  or  acquired  during  the  course  of  cultures. 
This, however, did not appear plausible since freshly prepared syngenic thymus 
ceils  possessed  such  antigen(s),  shown  by  the  absorption  of  the  antibodies 
lytic for LS178Y. Thus we are led to conclude that cells capable of recognizing 
surface antigens present on the animal's own thynms cells exist in the spleens 
of normal DBA/2 mice. 
The antigen under study had two outstanding characteristics: (a) it could be 
demonstrated on thymus cells, but not on any other murine tissue cells; and (b) 
its presence on thymus cells was not restricted to DBA/2, but was demonstrable 
in all other routine strains tested. Although the tissue distribution of the antigen 
resembled that of the thymic leukemia (TL) antigen (11), it was shown that the 
antibodies lyric to L5178Y  cells could also be absorbed by thymus cells from 
TL-negative strains such as AKR and C57BL/6. 
The results  of quantitative  absorption  experiments indicated  that L5178Y 
cells were 30 times more efficient in removing the antibodies than were thymus 
cells. This result is  consistent  with  the fact that  antibodies lytic for LS178Y 
ceils failed to lyse thymus cells, and may indicate that the antigen is either more 
strongly expressed on L5178Y lymphoma cells than on  thymus ceils or is ex- 
pressed  only in  a  minor population  of thymus cells.  The  latter possibility is tI.  FUJI  AND  F.  MILGROM  29 
supported by the fact that the 0-positive lymphoma EL4 of C57BL/6 origin 
(12) did not absorb the antibodies whereas the comparable number of C57BL/6 
thymus cells absorbed them completely, which may indicate heterogeneity in 
thymus cells with regard to the presence of the antigen under study. L5178Y 
lymphoma cells, which in our hands are also e positive, may thus have been 
derived from  the  minor  population  of  thymus  cells  carrying  the  particular 
antigen. 
Physicochemical characterization of the antibodies in S+T cultures showed 
that they were of IgM class.  It was further demonstrated that the binding of 
the antibodies to the antigen was more efficient at 4°C than at 22°C and that 
hardly any binding occurred  at  37°C.  It is  of interest to note that natural 
thymocytotoxic autoantibodies  demonstrated  in  the  sera  of  NZB  mice  by 
Shirai  and  Mellors  (10)  were  also IgM  antibodies  with optimal  activity at 
4°C and were directed against an antigen present on thymus cells of all strains 
tested. However, there are distinct differences between the antibodies lytic to 
L5178Y described here and those found in NZB mice: (a) NZB autoantibodies 
are thymocytotoxic (10)  and thymocytolytic as tested by cytolysis in agar,  2 
whereas the antibodies under discussion are not; and (b)  the antigen reacting 
with NZB antibodies is detected on cells from thymus, spleen, lymph node, and 
brain, whereas the antigen of this study seems to be restricted to thymus. 
It  has  recently  been  reported  that  in  vitro  autosensitization  of  normal 
lymphoid cells of rats and mice as measured by cell-mediated immunity could 
be induced against antigens on syngenic fibroblasts (13)  and syngenic thymus 
reticulum cells  (14).  The authors suggested the existence of lymphocytes that 
are reversibly tolerant to autoantigens and of regulatory mechanisms that may 
function in vivo to prevent differentiation of self-tolerant lymphocytes. The 
stimulation observed in our in vitro studies apparently does not occur, or seldom 
occurs,  in  vivo  under  physiologic conditions.  The  vast  majority of  normal 
DBA/2  mice  examined in  this  study did not have  any PFC  detectable  on 
L5178Y cells in their spleens. On the other hand, an intravenous administration 
of fresh syngenic thymus cells  has readily stimulated such animals, and the 
PFC lyric for L5178Y cells  could be detected in the spleens 4 days after the 
injection. It would appear, therefore, that the thymus cells carrying the stimu- 
lating antigen do not enter the circulation under physiologic conditions and, 
consequently, no PFC response occurs in the spleen of normal mice. 
Another  possible  explanation  of  the  recognition  by  DBA/2  mice  of  the 
antigens of the animal's own thymus would be that the antigen appears in the 
thymus after self-tolerance is established. Although our demonstration of the 
antigen in the fetal thymus of 16 days' gestation argues against this explanation, 
it cannot be excluded entirely. 
Significantly, our experiments showed that the ability to respond to the self 
2 Auer, I., T. Tomasi, and F. Miigrom. 1973. Natural  thymocytolytic autoantibodies in 
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antigen  under study is  a  strain-dependent phenomenon. Spleen cells  of NZB 
and  C57BL/6 mice did not respond to such antigen in vitro whereas DBA/2 
spleen cells have readily responded to stimulation in vitro and even in vivo. It 
is thus possible that the lack of self-tolerance observed in DBA/2 mice is due 
to genetically determined effects. It was shown that spleen cells of (DBA/2  ;< 
NZB)F1  hybrids  behaved like NZB  cells,  which  suggests  that  the  ability to 
respond to the thymic autoantigen may be a recessive trait. 
The strain NZB is well known for spontaneously developing autoantibodies 
to various antigens (15), and genetic studies  (16-20) have shown that one or 
more genes may be responsible for this property. The observation that NZB 
mice were negative for the autoantibody response in this study indicates that a 
different genetic control is involved here. To our knowledge there have not been 
any other reports on autoantibody production by DBA/2  mice, and  the im- 
munopathological significance of the phenomenon described in this study has to 
be clarified in the future. Moreover, the present in vitro system may provide a 
good means of studying the cellular basis of generations of self-tolerance and of 
its breakdown. 
Finally, it may be postulated that  the demonstrated antigen is of extrinsic 
origin  like  the  antigens  associated  with  infection  by  vertically  transmitted 
leukemia viruses. Although such a possibility cannot be completely excluded, 
we have no data to substantiate it. Our results only stress the possible genetic 
effects on the ability to respond to cell-surface antigens expressed on the animal's 
own cells. 
SUMMARY 
In vitro cultures of spleen cells  (S)  from normal 8-10-wk-old DBA/2J mice 
were  shown  to  develop a  small  number  of plaque-forming  cells  (PFC)  that 
released antibodies ]ytic to syngenic and autologous thymus cells as well as to 
syngenic lymphoma L5178Y cells used as the target in the PFC assay. A marked 
increase in the number of PFC detectable on L5178Y target cells was demon- 
strated  on day 4  in  the  cultures  of  S  cells  to  which  syngenic or  autologous 
thymus cells had been added (S+T) at time 0, whereas the PFC detectable on 
thymus cells in such cultures remained at a level similar to that in S cultures. 
This  suggested  that  two  populations  of  PFC  participated  in  the  observed 
phenomena. No PFC developed in the culture of thynms cells (T). The addition 
of the cell-free supernatants of 24-h cultures of T or of L5178¥ cells to syngenic 
S cultures also caused a specific increase in the number of the PFC detectable 
on LS178Y, which  suggested  that  certain immunogenic factors released from 
the T  cells stimulated the response observed in the S+T cultures. 
Antibodies of IgM nature were detected in the supernatants of S+T cultures 
by means of cytolysis in agar of L5178Y cells. Although such antibodies did not 
cause lysis of thymus cells,  they could be completely removed by absorption 
with normal adult or fetal thymus cells of syngenic origin. Still, the absorbing H.  FUJI AND  ~F.  MILGROM  31 
capacity of L5178Y was much higher than that of thymus cells. The absorption 
was more efficient  at 4°C than at 22°C,  and hardly any absorption occurred at 
37°C.  The  tissue  distribution  of  the  antigen  under  study  seemed  to  be  re- 
stricted  to thymus cells since no other murine tissue cells  tested removed the 
antibodies. 
The thymic antigen under study was not restricted  to strain DBA/2J and 
could be demonstrated on thymus cells of all other strains tested. On the other 
hand, the ability of spleen cells to respond in vitro to this antigen has thus far 
been  observed only in  DBA/2J mice.  Spleen  cells  of strains  C57BL/6J and 
NZB/BINJ as well  as  (DBA/2  X  NZB)F1 failed  to show any significant in- 
crease  in  the  PFC  response  detectable  on the LS178Y target when syngenic 
thymus cells or DBA/2J thymus cells were added. 
An  intravenous  injection  of  syngenic  thymus  cells  to  DBA/2J  mice  also 
caused  the  appearance  in  their  spleens  of  PFC  detectable  on  the  L5178Y 
target. 
The described  in vitro system may provide a  good means of studying the 
cellular basis of generation of self-tolerance and of its breakdown. 
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